Connor, Clark & Lunn Investment Management (CC&L)
ALLO icon

Connor, Clark & Lunn Investment Management (CC&L)’s Allogene Therapeutics ALLO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ALLO Stock Details ALLO Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-46,106
Closed -$526K – 1097
2022
Q2 		$526K Buy
+46,106
New +$526K ﹤0.01% 764